Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer

NCT02327819 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.

NCT NCT02327819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02327819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer
Lead sponsor
Tel-Aviv Sourasky Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2015
Completion date
Not reported
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary liver cancer